Ignite Creation Date:
2024-05-06 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 2:21 PM
Study NCT ID:
NCT05176080
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-05-06
First Post:
2021-11-18
Brief Title:
Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive HER2-negative Advanced Breast Cancer
Sponsor:
Henan Cancer Hospital
Organization:
Henan Cancer Hospital
Organization Data
Organization:
Henan Cancer Hospital
Class:
OTHER_GOV
Study ID:
BC-IIT-FMTN-SHR6390-ET
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Henan Cancer Hospital
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None